Barcelona will host BIO-Europe Spring in 2017, from 20 to 22 March. As member of the local committee, Biocat organizes different activities as part of the program.

Lessons learned 369

Biocat and CataloniaBio organizes this Lessons Learned, that bring together on February 21st a selection of experts and professionals to discuss the SME Instrument Program of the European Commission.

Artificial Intelligence

This B·Debate, co-organized with the IBE - CSIC / UPF and the CSIC, will bring together top experts concerned with the benefits and risks of Artificial Intelligence, particularly, but not exclusively, in the domain of web and social media next March 7-8.

Jobs Listing

The sector’s top place for job offers in Catalonia. The system incorporates RSS technology to get the latest updates.

BioRegion Directory

More than 700 companies and a wide network of research centers and science parks, universities, hospitals and support agencies are the cluster of life sciences in Catalonia.


A clinical trial on a therapeutic HIV vaccine has proven, for the first time ever, that in some cases the immune system of people infected with HIV can be reeducated to control the virus for long periods of time without...
Under the Accelerator program of the European consortium EIT Health, there are several grants available to entrepreneurs, SMEs, start-ups and spin-offs in the healthcare arena, in addition to training and acceleration...
The fellows in the latest edition of the d·HEALTH Barcelona master, organized by Biocat, have already started the first phase of the program: bootcamp. From 6 to 10 February, they participated in “Building the team”...

Upcoming events

24.02.2017 to 25.02.2017

CosmoCaixa · C/ Isaac Newton, 26 · Barcelona

24.02.2017 to 27.02.2017

Barcelona - Paris - London

Lessons Learned BioRegion

We want to know what was the main lesson learned from 2016 in the field of healthcare and the life sciences in Catalonia. We asked some of the key stakeholders in the sector: entrepreneurs, institutions, executives at hospitals and research centers and investors. This is what they told us.